Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
149
datasets available to search
ShareScore release 0.9.0
Dataset results
149 results for “vedolizumab”
Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab
ClinicalTrials.gov study NCT03056924. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study
ClinicalTrials.gov study NCT07093294. IPD Sharing: NO. Countries: 1. Publications: 0.
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
ClinicalTrials.gov study NCT06756152. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.
ClinicalTrials.gov study NCT02712866. IPD Sharing: NO. Countries: 1. Publications: 0.
The Safety Assessment of Vedolizumab During Pregnancy in IBD Patient
ClinicalTrials.gov study NCT02617927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Synergistic Effect of Vedolizumab and Pentoxifylline
ClinicalTrials.gov study NCT02953275. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
ClinicalTrials.gov study NCT06880744. IPD Sharing: YES. Countries: 31. Publications: 0.
Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®
ClinicalTrials.gov study NCT05771155. IPD Sharing: NO. Countries: 1. Publications: 0.
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
ClinicalTrials.gov study NCT06249555. IPD Sharing: NO. Countries: 2. Publications: 0.
VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease
ClinicalTrials.gov study NCT03257345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis
ClinicalTrials.gov study NCT04231110. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
ClinicalTrials.gov study NCT05281614. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis
ClinicalTrials.gov study NCT03237260. IPD Sharing: NO. Countries: 1. Publications: 0.
Vedolizumab for the Treatment of Collagenous Gastritis
ClinicalTrials.gov study NCT06317220. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vedolizumab efficacy is associated with decreased intracolonic dendritic cells, not memory T cells [P444]
GEO Series GSE234981. Homo sapiens. 346 samples. Type: Expression profiling by high throughput sequencing.
Differential effects of ontamalimab versus vedolizumab on immune cell trafficking in intestinal inflammation and IBD
GEO Series GSE230059. Mus musculus. 3 samples. Type: Expression profiling by high throughput sequencing.
Vedolizumab efficacy is associated with decreased intracolonic dendritic cells, not memory T cells [P430]
GEO Series GSE234736. Homo sapiens. 96 samples. Type: Expression profiling by high throughput sequencing.
Colon tissue gene expression associated with vedolizumab treatment effectiveness in ulcerative colitis.
GEO Series GSE282580. Homo sapiens. 60 samples. Type: Expression profiling by high throughput sequencing.
Responsiveness to vedolizumab therapy in ulcerative colitis is associated with alterations in immune cell-cell communications
GEO Series GSE228165. Homo sapiens. 54 samples. Type: Expression profiling by high throughput sequencing.
Transcriptional behavior of regulatory T cells predicts IBD patient responses to vedolizumab therapy
GEO Series GSE184593. Homo sapiens. 172 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.